CLIP
Leukemia vaccine trial shows 41% lower risk of death
Sellas Life Sciences CEO and founder Angelos Stergiou joins 'Fox & Friends' to discuss trial results for a new acute myeloid leukemia vaccine.
A breakthrough cancer vaccine trial sparks new hope for acute myeloid leukemia patients as results show a reduced death risk. Sellas Life Sciences CEO and founder Angelos Stergiou joins Brian Kilmeade to discuss the GPS vaccine trial that cut the risk of death by 41% compared to current treatments. The company utilizes artificial intelligence and plans to seek FDA approval.
Live Now
All times easternNOW - 10:30 AM
10:30 AM
11:00 AM
11:30 AM
12:00 PM
12:30 PM
